Tigenix S.A.U.

Industry · 11 registered clinical trials.

Status	Trial	Phase	Started
Completed	Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for Crohn's Disease	Phase 3	2017-09-15
Completed	Cx611-0204 SEPCELL Study Bacterial Pneumonia	Phase 1 / Phase 2	2017-01-30
Completed	Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Sepsis	Phase 1	2014-10-01
Completed	Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease Crohn's Disease	Phase 3	2012-07-01
Completed	Intralymphatic eASC Administration in Healthy Volunteers Localized Adverse Reaction to Administration of Drug	Phase 1	2012-01-01
Completed	Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients Rheumatoid Arthritis Aggravated	Phase 1 / Phase 2	2011-03-01
Completed	Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Crohn's Disease, Anal Fistula	Phase 1 / Phase 2	2009-06-01
Terminated	Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Dis Complex Perianal Fistula, Crohn Disease	Phase 3	2008-12-01
Completed	Long-term Safety and Efficacy of Adipose-derived Stem Cells to Treat Complex Perianal Fistulas in Patients Par Complex Perianal Fistula	—	2008-09-01
Completed	Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease Anal Fistula	Phase 3	2007-02-01
Completed	Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa EPIDERMOLYSIS BULLOSA	Phase 2	2006-12-01